English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52808717    線上人數 :  600
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu c"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 336-345 / 881 (共89頁)
<< < 29 30 31 32 33 34 35 36 37 38 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-03-15T06:27:34Z Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy Lin Z.-Z.; Hsu C.; Hu F.-C.; Shao Y.-Y.; DWANG-YING CHANG; Yang C.-H.; Hong R.-L.; Hsu C.-H.; Chengb A.-L.
臺大學術典藏 2021-03-15T06:27:33Z The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines Chen W.-W.; DWANG-YING CHANG; Huang S.-M.; Lin C.-H.; Hsu C.; Lin M.-H.; Huang C.-S.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏 2021-03-12T00:51:01Z Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer Chang Y.-T.;Chang M.-C.;Wei S.-C.;Tien Y.-W.;Hsu C.;Liang P.-C.;Tsao P.-N.;I-Shiow Jan;Wong J.-M.; Chang Y.-T.; Chang M.-C.; Wei S.-C.; Tien Y.-W.; Hsu C.; Liang P.-C.; Tsao P.-N.; I-SHIOW JAN; Wong J.-M.
臺大學術典藏 2021-03-09T06:46:18Z MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer Hsu C.;Yeh K.-H.;Ruey-Long Hong;Yang C.-H.;Lin M.-T.;Chen Y.-C.;Cheng A.-L.; Hsu C.; Yeh K.-H.; RUEY-LONG HONG; Yang C.-H.; Lin M.-T.; Chen Y.-C.; Cheng A.-L.
臺大學術典藏 2021-03-09T06:46:11Z Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate Lin C.-H.;Yen R.-F.;Jeng Y.-M.;Tzen C.-Y.;Hsu C.;Ruey-Long Hong; Lin C.-H.; Yen R.-F.; Jeng Y.-M.; Tzen C.-Y.; Hsu C.; RUEY-LONG HONG
臺大學術典藏 2021-03-09T06:46:10Z Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysis Hsu C.;Shen Y.-C.;Cheng C.-C.;Ruey-Long Hong;Chang C.-J.;Cheng A.-L.; Hsu C.; Shen Y.-C.; Cheng C.-C.; RUEY-LONG HONG; Chang C.-J.; Cheng A.-L.
臺大學術典藏 2021-03-09T06:46:06Z Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy Lin Z.-Z.; Hsu C.; Hu F.-C.; Shao Y.-Y.; Chang D.-Y.; Yang C.-H.; RUEY-LONG HONG; Hsu C.-H.; Chengb A.-L.
臺大學術典藏 2021-03-09T05:27:30Z Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival Ying-Chun Shen; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; Lin Z.-Z.; Chang M.-C.; Hsu C.; Cheng A.-L.
臺大學術典藏 2021-03-09T05:18:40Z Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract Hsu C.; Ying-Chun Shen; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; Cheng A.-L.
臺大學術典藏 2021-03-09T05:18:39Z Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysis Hsu C.; Ying-Chun Shen; Cheng C.-C.; Hong R.-L.; Chang C.-J.; Cheng A.-L.

顯示項目 336-345 / 881 (共89頁)
<< < 29 30 31 32 33 34 35 36 37 38 > >>
每頁顯示[10|25|50]項目